Congenital myasthenia and congenital disorders of glycosylation caused by mutations in the DPAGT1 gene
Neurologia (Engl Ed). 2019 Mar;34(2):139-141.
doi: 10.1016/j.nrl.2017.05.002.
Epub 2017 Jul 13.
[Article in
English,
Spanish]
Affiliations
- 1 Sección de Neuropediatría, Servicio de Pediatría, Hospital Virgen de la Arrixaca, Murcia, España. Electronic address: [email protected].
- 2 Sección de Neuropediatría, Servicio de Pediatría, Hospital Virgen de la Arrixaca, Murcia, España.
- 3 Centro de Diagnóstico de Enfermedades Moleculares (CEDEM), Universidad Autónoma de Madrid, Madrid, España.
No abstract available
MeSH terms
-
Autism Spectrum Disorder
-
Child
-
Cholinesterase Inhibitors / therapeutic use
-
Congenital Disorders of Glycosylation / genetics*
-
Humans
-
Mutation / genetics*
-
Myasthenic Syndromes, Congenital / genetics*
-
N-Acetylglucosaminyltransferases / genetics*
-
Pyridostigmine Bromide / therapeutic use
Substances
-
Cholinesterase Inhibitors
-
N-Acetylglucosaminyltransferases
-
dolichyl-phosphate alpha-N-acetylglucosaminyltransferase
-
Pyridostigmine Bromide